\
&
Contact us
\
&
Contact us
This was 1 year ago
LocationBrussels
The use of synthetic data has emerged as an interesting technique to respond to the increasing demands for data to fuel data analytics and AI, especially in cases where sensitive information is involved.
This event, organised by the European Commission, will showcase the potential of synthetic data and explore potential limitations in ensuring full information privacy.
The panellists during this conference will discuss the role that synthetic data can play in the digital economy, strategies to promote its use and the associated risks.
For more information on the agenda and to register, please visit the event website. Please note that due to the limited capacity of the venue, registrations are subject to validation by the organisers.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health Culture and society Digital, Industry & Space Climate, Energy, Mobility Agro-Food, Environment
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
